Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/LANDOS-BIOPHARMA-INC-118621689/actualite/Landos-Biopharma-Inc-Publie-les-resultats-de-l-etude-de-phase-1b-du-NX-13-sur-la-colite-ulcereu-45409855/?utm_source=whatsapp&utm_medium=social&utm_campaign=share